From this result, we concluded that antagonistic anti-CD200R1 antibody promoted T-cell receptor-driven proliferation of CD4+ T cells in SLE patients, implying that endogenous CD200-CD200R1 interactions limited T-cell proliferation in SLE patients. This evidence concerns the gene CD200 and systemic lupus erythematosus.